The International Takotsubo Registry
was established in 2011 by a dedicated team of physicans at the Cardiovacular Center of Zurich, Switzerland to find the pathophysiology, epidemiologic features and clinical course of this important disease.
The mission of the registry is to establish a unique worldwide database with the largest cohort of patients with Takotsubo cardiomyopathy. This registry is designed to collect data on the current status and follow-up of patients with Takotsubo cardiomyopathy, including:
- demographic data
- clinical profile
- treatment strategy
- quality of life
- geographic variation
Our main goals are to:
- compare clinical practice regarding to diagnosis and management
- promote medical resource and its impact on outcome in different countries
- analyse prospectively the value of different treatment strategies to predict disease related outcomes
- observe the follow up status at 30-day, 6-month and one year and to assess the immediate, in-hospital and long-term outcome
- assess pathophysiology and to find a biomarker of TTC
The registry aims to provide a better understanding of TTC to improve the management of these patients in daily routine and enhance clinical outcome.